Article Per Year (5 Year)
p-Index From 2021 - 2026
3.24
P-Index
This Author published in this journals
All Journal Medical Journal of Indonesia Indonesian Journal of Obstetrics and Gynecology (Majalah Obstetri dan Ginekologi Indonesia) Jurnal Sinaps Majalah Kedokteran Neurosains Journal of the Indonesian Medical Association : Majalah Kedokteran Indonesia Indonesian Journal of Cancer eJournal Kedokteran Indonesia Neurona Acta Neurologica Indonesia
Tiara Aninditha Tiara Aninditha
Departemen Neurologi FK Universitas Indonesia/RSUPN Dr. Cipto Mangunkusumo, Jakarta
Biochemistry, Genetics & Molecular Biology Education Health Professions Immunology & microbiology Medicine & Pharmacology Neuroscience Public Health

Published : 40 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 40 Documents
Search

 1   2   3   4 
KARAKTERISTIK METASTASIS SISTEM SARAF PUSAT DARI KANKER PARU Tan Yosephine*, Tiara Aninditha**, Henry Riyanto Sofyan**, Jonathan Odilo***, Rini Andriani****
NEURONA Vol. 37 No. 4 September 2020
Publisher : Neurona Majalah Kedokteran Neuro Sains

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

INTRODUCTION A S MUCH AS 40 OF LUNG CANCER PATIENTS WILL EXPERIENCE CENTRAL NERVOUS SYSTEM CNS METASTASIS IN THE COURSE OF THE DISEASE FROM THOSE 40 AS MUCH AS 39 WILL EXPERIENCE LEPTOMENINGEAL METASTASIS BUT THE CLINICAL PROFILE OF CNS INVOLVEMENT IN LUNG CANCER HAS NEVER BEEN STUDIED BEFORE IN INDONESIA
FUNGSI KOGNITIF PADA PASIEN TUMOR OTAK METASTASIS PASCA RADIASI WHOLE BRAIN RADIOTHERAPY DI DUA RS RUJUKAN KANKER INDONESIA Rahmi Ardhini,* Tiara Aninditha,** Rini Andriani,*** Henry Riyanto Sofyan**
NEURONA Vol. 38 No. 1 Desember 2020
Publisher : Neurona Majalah Kedokteran Neuro Sains

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

METASTASES REPRESENT ONE OF THE MOST COMMON NEUROLOGICAL COMPLICATIONS OF SYSTEMIC CANCER WITH AN INCIDENCE WAS ABOUT 40 WHOLE BRAIN RADIOTHERAPY WBRT IS A STANDARD TREATMENT TO REDUCE TUMOR VOLUME AND INCREASING PATIENTS SURVIVAL BUT WBRT HAS A SIDE EFFECTS DUE TO RADIATION EXPOSURE TO THE BRAIN PARENCHYMA INCLUDING COGNITIVE IMPAIRMENT
LAPORAN KASUS: TERAPI BROMOCRIPTINE PADA PROLAKTINOMA YANG TELAH MELUAS KE EKSTRASELA: BROMOCRIPTINE THERAPY IN AN EXTRA-SELLARLY EXPANDED PROLACTINOMA Arthur H.P. Mawuntu; Tiara Aninditha
Jurnal Sinaps Vol. 1 No. 2 (2018): volume 1 Nomor 2, Juni 2018
Publisher : Neurologi Manado

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (520.379 KB)

Abstract

Prolaktinoma adalah neoplasma jinak yang mencakup sekitar 40% dari seluruh tumor hipofisis. Lebih daripada 90% kasus merupakan tumor yang kecil dan terbatas dalam sella turcica. Pada beberapa kasus, prolaktinoma bisa membesar menjadi suatu makroadenoma hipofisis yang menimbulkan gejala defisit neurologis selain gangguan endokrinologis. Secara umum telah diterima bahwa prolaktinoma berespons baik terhadap terapi dengan agonis dopamin seperti bromocriptine namun prolaktinoma yang telah meluas ke luar sella turcica diterapi dengan agonis dopamin maupun kombinasi agonis dopamin dan pembedahan. Kami mengobati suatu prolaktinoma besar yang telah meluas ke ruang ekstraselar dengan bromocriptine dosis total 7,5mg per hari, diawali dengan dosis 1,25mg per hari yang dititrasi selama empat minggu sambil menunggu jadwal operasi. CT scan kontrol menunjukkan pengecilan massa tumor yang bermakna sehingga operasi dibatalkan. Kata kunci: bromocriptine – agonis dopamin – prolaktinoma. ABSTRACT Prolactinoma is a benign neoplasm which account for about 40% of all pituitary tumors. Over 90% of these cases are small intra-sellar tumors. In few cases, prolactinoma can grow and become a pituitary macroadenoma that caused neurological deficit despite endocrinological disorders. It is generally accepted that prolactinomas have a good response to dopamine agonist therapy such as bromocriptine but extra-sellarly expanded prolactinoma is be treated with dopamin agonist or combination between dopamin agonist and surgery. We treated a patient with a large prolactinoma that has expanded extra-sellarly using a total dose of 7,5mg bromocriptine each day tappered from 1,25mg per day for four weeks while scheduled for surgery. The control CT scan showed a significant reduction in tumor size that leaded to cancellation of surgery. Keywords: bromocriptine – dopamine agonists – prolactinoma.
Pengaruh Pembelajaran Jarak Jauh Akibat Pandemi COVID-19 Terhadap Tingkat Keparahan Nyeri Kepala Primer Tiara Aninditha; Stefen Weliadi Ali
eJournal Kedokteran Indonesia Vol 10, No. 3 - Desember 2022
Publisher : Faculty of Medicine Universitas Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.23886/ejki.10.225.219-17

Abstract

Abstrak Pembelajaran jarak jauh (PJJ) selama masa pandemi COVID-19 dapat menyebabkan peningkatan durasi penggunaan gawai, peningkatan stres dan kualitas tidur buruk pada mahasiswa dimana hal-hal tersebut dapat berkaitan dengan kejadian nyeri kepala primer. Penelitian ini bertujuan untuk mengetahui hubungan PJJ dengan tingkat keparahan nyeri kepala primer. Studi ini merupakan studi potong lintang, analitik observasional. Sampel diambil secara konsekutif mulai Desember 2020 sampai Mei 2021 menggunakan kuesioner elektronik kepada mahasiswa preklinik FKUI angkatan 2018, 2019 dan 2020. Tingkat stres diukur dengan PSS-10 dan kualitas tidur dengan PSQI. Terdapat 95 subyek nyeri kepala primer yang memenuhi kriteria (24,1%) dari total 393 responden. Mayoritas subyek (93,7%) mengalami peningkatan durasi penggunaan gawai selama PJJ dengan rerata 12,67±3,28 jam. Peningkatan durasi penggunaan gawai memiliki hubungan signifikan dengan peningkatan tingkat keparahan nyeri kepala primer (p=0,04). Sekitar 80% subyek mengalami stres sedang-berat dan 71,6% memiliki kualitas tidur buruk selama PJJ, namun tidak terdapat hubungan signifikan dengan peningkatan tingkat keparahan nyeri kepala primer (p>0,05). Oleh karena itu, dapat disimpulkan bahwa terdapat hubungan bermakna antara peningkatan durasi penggunaan gawai dengan tingkat keparahan nyeri kepala primer. Kata kunci: durasi penggunaan gawai, kualitas tidur, nyeri kepala primer, pembelajaran jarak jauh, tingkat stres
FAKTOR-FAKTOR YANG MEMENGARUHI STATUS PERFORMA PASIEN TUMOR INTRAKRANIAL DI RSUPN DR. CIPTO MANGUNKUSUMO Mariana Nur Laila; Rini Andriani; Henry Riyanto Sofyan; Tiara Aninditha
NEURONA Vol 37 No 1 (2019)
Publisher : PERDOSNI

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52386/neurona.v37i1.91

Abstract

FACTORS INFLUENCING PERFORMANCE STATUS IN PATIENTS WITH INTRACRANIAL TUMOR AT CIPTO MANGUNKUSUMO GENERAL HOSPITALABSTRACTIntroduction: Patients diagnosed with malignancy have a long course of illness from diagnosis to treatment. Assessment of performance status (PS) is essential to give an overview of therapeutic readiness and patient’s prognosis. Karnofsky Performance Scale is a PS assessment used widely in neurooncology patients. This instrument can assess functional impairment among patients. To this date, clinical factors in admission time that influences KPS in hospitalized intracranial tumor has not been researched.Aim: To get an overview of KPS in hospitalized intracranial  patients in Cipto Mangunkusumo General Hospital and to investigate factors that influence.Methods: The design of this research was cohort retrospective. The research was done in Cipto Mangunkusumo General Hospital using secondary data in 2015-2016. The subjects of the research were patients with intracranial tumors. Demographic, clinical status in admission, pathological anatomy, and performance status data were acquired. The data were processed and presented descriptively and analytically. Independent predictors investigated using multivariate logistic regression.Results: There were 68 subjects obtained in this research. As much as 35 (51.5%) subject had primary intracranial tumor. As much as 58 (85.2%) subjects aged <60 years old. As much as 51 (76.5%) subjects had supratentorial tumor. Majority of subjects (70%) had KPS score <70. Subjects with primary tumor had more cranial nerve palsy (p=0.021) and hemiparesis (p=0.038). Decreased consciousness increased the risk of KPS score <70 by 5.2x in the time of admission.Discussion: Majority of subjects had KPS score <70. Decreased consciousness in the time of admission is an independent predictive factor that lowers KPS.Keywords: Karnofsky Performance Scale, intracranial tumor, neurooncology, risk factorsABSTRAKPendahuluan: Pasien keganasan memiliki perjalanan penyakit yang panjang mulai dari diagnosis hingga tata laksana. Kondisi pasien dapat sangat beragam, sehingga penting dilakukan pengkajian status performa untuk memberikan gambaran kesiapan terapi dan prognosisnya. Instrumen yang paling sering digunakan secara standar internasional adalah Karnofsky Performance Scale (KPS). Sejauh ini belum diketahui penggunaan KPS pada pasien tumor intrakranial, mengingat performa pasien yang tidak hanya disebabkan oleh keganasannya, namun juga kecacatan akibat dari lesinya.Tujuan: Mendapatkan gambaran KPS pasien tumor intrakranial serta faktor-faktor yang memengaruhinya.Metode: Penelitian kohort retrospektif terhadap pasien tumor intrakranial yang dirawat di RSUPN Dr. Cipto Mangunkusumo, Jakarta, pada tahun 2015-2016. Dilakukan pencatatan karakteristik demografik pasien, faktor klinis saat admisi, patologi anatomi, dan KPS. Data disajikan secara deskriptif dan analitik, faktor prediktor independen diinvestigasi menggunakan analisis multivariat regresi logistik.Hasil: Didapatkan 68 subjek dalam penelitian ini dengan proporsi tumor primer dan sekunder sebanyak 33 dan 35 orang. Subjek perempuan lebih banyak pada kelompok tumor primer dan lebih sedikit pada tumor sekunder. Mayoritas subjek berusia <60 tahun (85,2%), lokasi tumor di supratentorial (76,5%), dan KPS masuk <70 (69,2%). Subjek dengan penurunan kesadaran saat masuk perawatan akan cenderung memiliki KPS <70 (p=0,005) dibanding faktor-faktor klinis lainnya dengan risiko 5,2x menyebabkan status performa yang rendah tersebut saat admisi.Diskusi: Sebagian besar subjek memiliki nilai KPS <70. Penurunan kesadaran saat admisi merupakan faktor prediktif independen penurunan KPS.Kata kunci: Faktor risiko, Karnofsky Performance Scale, neuroonkologi, tumor intrakranial
PENGARUH HIPERKOAGULASI TERHADAP MORTALITAS ASTROSITOMA PADA PEMANTAUAN 12 BULAN Among Wibowo; Tiara Aninditha; Henry Riyanto Sofyan; Rini Andriani
NEURONA Vol 37 No 1 (2019)
Publisher : PERDOSNI

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52386/neurona.v37i1.96

Abstract

EFFECT OF HYPERCOAGULABILITY TO ASTROCYTOMA MORTALITY WITHIN 12-MONTHS OF FOLLOW UPABSTRACTIntroduction: Astrocytoma is the most common primary brain tumor. Hypercoagulable state is one of brain tumor complications which can cause vein thromboembolism (VTE). Vein thromboembolism incidence is increased in astrocytoma patients. Hypercoagulable state in astrocytoma could lower patient’s survival.Aim: To investigate the effect of hypercoagulable state on mortality within 12 months of follow up in astrocytoma patients.Methods: This study design was retrospective cohort. This research data was taken from medical records in Cipto Mangunkusumo General Hospital and Dharmais Cancer Center Hospital on December 2017-February 2018. The subjects were adult astrocytoma patients who had histopathology and hemostasis examination. The variables investigated in this study were gender, age, prothrombin time (PT), activated partial thromboplastin time (aPTT), and D-dimer. Data processed descriptively and analytically using SPSS ver. 20 for Windows.Results: There were 49 subjects in this research. Around 30 (61.2%) subjects were men and 20 (40.8%) subjects aged >50 years old. High grade glioma was found in 39 (79.6%) subjects and hypercoagulable state was found in 34 (69.4%) subjects. There were 20 subjects deceased in 12-month follow-up. Subjects with hypercoagulable state had relative risk (RR) of 3.97 more susceptible to die in 12-month follow-up compared to control (p=0.009).Discussion: Hypercoagulation was a mortality risk factor in 12-month follow-up in patients with astrocytoma.Keywords: Astrocytoma, hypercoagulation, mortality within 12-months of follow upABSTRAKPendahuluan: Astrositoma merupakan tumor otak primer yang paling sering ditemukan. Salah satu komplikasi dari tumor otak adalah keadaan hiperkoagulasi. Keadaan hiperkoagulasi dapat menyebabkan tromboemboli vena. Insiden tromboemboli vena meningkat pada astrositoma. Keadaan hiperkoagulasi pada astrositoma dapat menurunkan kesintasan atau meningkatkan mortalitas pada pasien astrositoma.Tujuan: Mengetahui pengaruh hiperkoagulasi pada mortalitas pasien astrositoma dalam 12 bulan pemantauan.Metode: Penelitian kohort retrospektif terhadap pasien tumor otak jenis astrositoma yang dirawat oleh Divisi Neuroonkologi di RSUPN Dr. Cipto Mangunkusumo (RSCM) dan RS Pusat Kanker Dharmais (RSKD) pada bulan Desember 2017 hingga Februari 2018. Sumber data adalah data sekunder berupa rekam medis pasien dewasa yang telah memiliki hasil pemeriksaan histopatologis dan hemostasis. Variabel yang diambil dalam penelitian ini adalah jenis kelamin, usia, prothrombin time (PT), activated partial thromboplastin time (aPTT), dan D-dimer. Data diolah secara deskriptif dan analitik bivariat menggunakan SPSS ver. 20 for Windows.Hasil: Terdapat 49 subjek dalam penelitian ini yang mayoritas (61,2%) laki-laki, berusia <50 tahun (59,2%), dan memiliki jenis high grade gliomas (75,8%). Sebagian besar subjek mengalami hiperkoagulasi (69,4%) dan dalam kondisi hidup (59,2%) pada 12 bulan pascaperawatan. Subjek dengan hiperkoagulasi memiliki risiko relatif (RR) 3,97 kali lebih rentan mengalami kematian setelah 12 bulan dibandingkan kontrol (p=0,009).Diskusi: Hiperkoagulasi merupakan salah satu faktor risiko kematian dalam 12 bulan pada pasien astrositoma.Kata kunci: Astrositoma, hiperkoagulasi, mortalitas 12 bulan
PREVALENSI NYERI NEUROPATIK PADA PASIEN DENGAN NYERI KANKER DI RSUPN DR CIPTO MANGUNKUSUMO DAN PKN RS DHARMAIS Henry Riyanto Sofyan; Tiara Aninditha; Louis Kwandou; Jonathan Odilo; Rini Andriani
NEURONA Vol 37 No 3 (2020)
Publisher : PERDOSNI

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52386/neurona.v37i3.160

Abstract

Introduction: Cancer pain is one of the most common complications in cancer. As much as 30-50% of cancer patients experienced pain. Cancer pain patients have reported complaints of pain with a neuropathic component. Early diagnosis of neuropathic cancer pain has a clinical implication for patient management. However, the proportion of neuropathic cancer pain has not been studied in Indonesian population. Aim: The study was to get an overview of neuropathic pain prevalence among cancer pain patients in Cipto Mangunkusumo General Hospital and National Cancer Referral Dharmais Hospital. Methods: The design of this research was cross-sectional. The study was done in Cipto Mangunkusumo General Hospital and National Cancer Referral Dharmais Hospital in July-September 2019. The subjects in this research were adult cancer patients who consulted with the Department of Neurology. The data acquired were patient’s demography, cancer history, imaging, and pain assessment. PainDETECT questionnaire was employed to assess neuropathic pain. The data were processed and presented descriptively and analytically. Results: There were 57 subjects obtained in this research with average age of 45.91. As much as 31.6% subjects had neuropathic cancer pain. Breast cancer identified in 38.6% subjects. There were no differences of gender, age, cancer type, and pain intensity between subjects with and without neuropathic cancer pain. Radiating pain and subject with metastasis experienced neuropathic cancer pain more frequently. Discussion: The prevalence of neuropathic cancer pain in the Indonesian population is 31.6%. Radiating pain and patients with metastasis cancer tend to experienced neuropathic pain more frequently. Keywords: Cancer, Indonesia, neuropathic pain, prevalence
KESINTASAN PASIEN DENGAN METASTASIS LEPTOMENINGEAL YANG DIRAWAT DI BAGIAN NEUROLOGI RUMAH SAKIT KANKER DHARMAIS DAN RSUPN DR CIPTO MANGUNKUSUMO Elsa Susanti; Rini Andriani; Tiara Aninditha; Henry Riyanto Sofyan
NEURONA Vol 37 No 4 (2020)
Publisher : PERDOSNI

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52386/neurona.v37i4.172

Abstract

Introduction: Leptomeningeal metastasis is a condition where malignant cells spread to the leptomening and subarachnoid space. This is an emergency state with incident tends to increase each year. Prognosis is very poor and survival rate is only 10-15 weeks. Aim: To determine survival of leptomeningeal metastasis patients in Cancer Dharmais Hospital and Cipto Mangunkusumo Hospital. Methods: This is a retrospective cohort research based on medical records of leptomeningeal metastasis patients in Cancer Dharmais Hospital and Cipto Mangunkusumo Hospital from January 2018 to June 2019. Clinical examination, liquor cerebral examination, MRI, and histopathological of primary tumours were written. Subjects or family of the subjects were contacted to obtain information about subject’s wellbeing whether they’re still alive or dead. If they’re unreachable they will be excluded. Survival of each subject was determined based on how long the subject remain alive since being diagnosed with leptomeningeal metastasis until the end of observation, which is the end of the research. Results: Sixty two patients were included in the research, 21 were males and 41 were females. Headache was the most frequent symptoms found in the patients (46.8%) followed by cranial nerves deficits (45.2%). Median survival in this research was 13 weeks, no significant differences in survival from haematologic malignancy and solid tumor. Discussion: Median survival of leptomeningeal metastasis patients was 13 weeks, there was no statistically significant difference between survival of heamotologic malignancy and solid tumor. Median survival in leptomeningeal metastasis in this research remain poor regardless the origin of the metastasis. Keywords: Haematologic malignancy, leptomeningeal metastasis, solid tumor, survival
KARAKTERISTIK METASTASIS SISTEM SARAF PUSAT DARI KANKER PARU Tan Yosephine; Tiara Aninditha; Henry Riyanto Sofyan; Jonathan Odilo; Rini Andriani
NEURONA Vol 37 No 4 (2020)
Publisher : PERDOSNI

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52386/neurona.v37i4.174

Abstract

Introduction: As much as 40% of lung cancer patients will experience central nervous system (CNS) metastasis in the course of the disease. From those 40%, as much as 3-9% will experience leptomeningeal metastasis, but the clinical profile of CNS involvement in lung cancer has never been studied before in Indonesia. Aim: To give a description of CNS metastasis from lung cancer inCipto Mangunkusumo General Hospital and National Cancer Referral Dharmais Hospital. Methods: This is a cross-sectional study done in patients consulted to Neurology Department inCipto Mangunkusumo General Hospital and National Cancer Referral Dharmais Hospital in 2018. Inclusion cirteria is adult patients diagnosed with lung cancer based on histopathology with complete medical record to the extent of CT scan or Head MRI with contrast. Results: There were 48 subjects with median age of 57 (36-76) years, men were more than women (56.2% vs 44.8%) and 31.3% had history of smoking. The most frequent lung cancer type is non-small cell lung cancer (NSCLC) (93,8%). Neurological symptoms found were motoric deficits (62.5%), headache (43.8%), cognitive dysfunction (20.8%), and seizure (18.8%). Majority of subjects suffered from brain metastasis (93.8%) and 8.3% were leptomeningeal metastasis. Discussion: The majority of CNS metastasis were brain metastasis from NSCLC (93.8%) with main neurological deficits were motoric deficits (62.5%) and headache (43.8%). Keywords: Brain metastasis, lung cancer, non-small cell lung carcinoma
FUNGSI KOGNITIF PADA PASIEN TUMOR OTAK METASTASIS PASCA RADIASI WHOLE BRAIN RADIOTHERAPY DI DUA RS RUJUKAN KANKER INDONESIA Rahmi Ardhini; Tiara Aninditha; Rini Andriani; Henry Riyanto Sofyan
NEURONA Vol 38 No 1 (2020)
Publisher : PERDOSNI

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Brain metastases represent one of the most common neurological complications of systemic cancer, with an incidence was about 40%. Whole brain radiotherapy (WBRT) is a standard treatment to reduce tumor volume and increasing patient’s survival, but WBRT has a side effects due to radiation exposure to the brain parenchyma, including cognitive impairment. This was case series of 8 brain metastases patients, consist of 4 male and 4 female who have undergone radiation on April until June 2018. Cognitive function was assessed using Montreal Cognitive Assessment-Indonesian Version (MoCA-Ina) before and after WBRT. Collected data were age, sex, educational status, number of lesions, tumor site, clinical symptoms, Karnofsky Performance Status (KPS) score, extracranial metastases, radiation dose, primary cancer, hypertension, and diabetes mellitus. Most are multiple lesions and located in parietal lobe. The most common symptom was cognitive impairment. Seven patients already experienced cognitive impairment before WBRT and mostly have improved cognitive function after WBRT. Memory function was impaired in all subjects before WBRT that did not improved afterwards, but other domains including attention, language, executive function, and visuospatial were improved after WBRT. Key word: brain metastases, cognitive function, whole brain radiotherapy.
Co-Authors -, Liana Alviah Saputri Adriana Damayanti Agiananda, Feranindhya Ahmad Rafi Faiq Ahmad Yanuar Albertin, Elizabeth Alvonsius Silalahi, Raymond Aris Nimrod Alvonsius, Raymond Aris Nimrod Among Wibowo Anastasia Asylia Dinakrisma Andayani, Diyah Eka Andhika Rachman Andira Larasari Anne Dina Subroto Ardhi Rahman Ahani Aria Kekalih Ariarini, Ni Nengah Rida Arthur H.P. Mawuntu Audrey Clarissa David Tandian Diafiri, Dinda Djohansjah, Joice Rosewitasari Aryanti Dyah Ayu Puspita Anggarsari Eka Susanto Elsa Susanti Eny Nurhayati Ery Riady Indrapriambada Fahmi Radityamurti Faiq, Ahmad Rafi Ferucha Moulanda Hakim, Manfaluthy Hartono, Chandra Henry Riyanto Sofyan Henry Riyanto Sofyan Henry Riyanto Sofyan Henry Riyanto Sofyan Henry Riyanto Sofyan Henry Riyanto Sofyan Hervita Diatri Humaira, Sarah Ikhlas Rahmadi Imran, Darma Indrapriambada, Ery Riady Irma Savitri Irma Savitri Irma Savitri Madjid IRWANTO Jonathan Odilo Jonathan Odilo Karnasih, Artasya Kartika Maharani Kemal Fariz Kalista Kusuma, Radius Louis Kwandou Madjid, Irma Savitri Mariana Nur Laila Maulina, Lisa Mohamad Saekhu Natadisastra, Raden Muharram Nugraeni, Tiara Nur Afany Nurmiati Amir Pratiwi, Intan Prayangga, Regina Profitasari Kusumaningrum Pukovisa Prawiroharjo, Pukovisa Puspaseruni, Putri Air Putri Auliya, Putri Radius Kusuma Rahmad Mulyadi Rahmi Ardhini Ramdinal Aviesena Zairinal Ranakusuma, Teguh Ranakusuma, Teguh A. S Renindra Ananda Aman Rini Andriani Rini Andriani Rini Andriani Rini Andriani Rini Andriani Rini Andriani Rini Andriani Ririhena, Fiorentina C Riwanti Estiasari Riyanto Sofyan, Henry Saekhu, Mohammad Samjunanto, Achmad Sari, Riska Nanda Savitri, Irma Sembiring, Saulina Sinthia, Novita Ayu Sitorus, Freddy Sofyan, Henry Riyanto Sophie Yolanda Stefen Weliadi Ali Susanto, Eka Tan Yosephine Tanjung, Gloria Tejomukti, Teddy Tiara Aninditha Velyani, Dyani Pitra Vera Nevada Wahmurti, Tuti Wibisono, Sasanto Winnugroho Wiratman Yesi Astri Yesnuar Safri, Ahmad Yetty Ramli Yulian, Erwin D.